Emiel A. M. Janssen - Concepedia

Author

Emiel A. M. Janssen

Also Known As

E A M Janssen, E Janssen, E. A. Janssen, E. A. M. Janssen, E. Janssen, E.A.M Janssen, E.A.M. Janssen, EMIEL A. M. JANSSEN, Emiel A M Janssen, Emiel A. Janssen

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Stavanger University Hospital University of Bergen University of Amsterdam University of Stavanger The University of Texas MD Anderson Cancer Center

About

Emiel A. M. Janssen is an author at Stavanger University Hospital specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	895
2	Cell Biology	3	3	131
3	Public Health	2	2	70
4	Engineering	1	1	18
5	Health Sciences	1	1	27

Emiel A. M. Janssen

Publications

Citations

H-Index

Page 1

	Year	Citations
Olaparib monotherapy as primary treatment in unselected triple negative breast cancer Hans Petter Eikesdal, Synnøve Yndestad, Ahmed El‐Zawahry, Annals of Oncology	2020	210
De-novo mutation in hereditary motor and sensory neuropathy type I Jessica E. Hoogendijk, Gerard W. Hensels, Emiel A. M. Janssen, The Lancet Rare DiseasesHereditary MotorMendelian DisorderGenetic DisorderMedicine	1992	161
Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer Einar Gudlaugsson, Ivar Skaland, Emiel A. M. Janssen, Histopathology	2012	128
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial Xavier Pivot, Gilles Romieu, Marc Debled, The Lancet Breast OncologyOncologyEarly Breast CancerRandomised TrialBreast Cancer	2019	125
Prospective Multicenter Validation of the Independent Prognostic Value of the Mitotic Activity Index in Lymph Node–Negative Breast Cancer Patients Younger Than 55 Years Jan P. A. Baak, P. J. van Diest, Feja J. Voorhorst, Journal of Clinical Oncology	2005	112
Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age Ivar Skaland, Emiel A. M. Janssen, Einar Gudlaugsson, Modern Pathology Phosphohistone H3 ExpressionBreast OncologyMedicinePathologyStronger Prognostic Value	2007	108
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients Thomas Helland, Nina Henne, Ersilia Bifulco, Breast Cancer Research	2017	79
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study Shristi Bhattarai, Sergey Klimov, Karuna Mittal, Cancers	2019	74
Deletions in Xq28 in Two Boys with Myotubular Myopathy and Abnormal Genital Development Define a New Contiguous Gene Syndrome in a 430 kb Region L.-J. Hu, Jocelyn Laporte, Petra Kioschis, Human Molecular Genetics GeneticsGenetic EpidemiologyPathologyMolecular GeneticsDisease Gene Identification	1996	68
Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression Jan P. A. Baak, Bianca van Diermen, Anita Steinbakk, Human Pathology Tumor BiologyEndometrial Intraepithelial NeoplasiaTumoral PathologyMedicinePten Expression	2005	66

Page 1